Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy.

× No keyword cloud information.

5 in total

1. Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.

Authors: Yu-Tzu Tai; Holly M Horton; Sun-Young Kong; Erik Pong; Hsing Chen; Saso Cemerski; Matthew J Bernett; Duc-Hanh T Nguyen; Sher Karki; Seung Y Chu; Greg A Lazar; Nikhil C Munshi; John R Desjarlais; Kenneth C Anderson; Umesh S Muchhal
Journal: Blood Date: 2012-01-13 Impact factor: 22.113

Review 2. Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors: Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal: Br J Haematol Date: 2010-08 Impact factor: 6.998

3. Rituximab-induced tumor progression: does it really happen?

Authors: Mustafa Ozguroglu; Hande Turna
Journal: Med Oncol Date: 2004 Impact factor: 3.064

4. Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.

Authors: Mingjun Zhang; Jianfei Qian; Yongsheng Lan; Yong Lu; Haiyan Li; Bangxing Hong; Yuhuan Zheng; Jin He; Jing Yang; Qing Yi
Journal: Int J Cancer Date: 2014-02-07 Impact factor: 7.396

Review 5. Multiple myeloma in the marrow: pathogenesis and treatments.

Authors: Heather Fairfield; Carolyne Falank; Lindsey Avery; Michaela R Reagan
Journal: Ann N Y Acad Sci Date: 2016-01 Impact factor: 5.691

5 in total